| Database ID | Agent | Target | Cancer Type | Detail |
| DB00751 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00752 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00753 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00754 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00755 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00756 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00757 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00758 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | non small cell lung cancer | view |
| DB00759 | everolimus | Serine/threonineprotein kinase mTOR | advanced adenoid cystic carcinoma | view |
| DB00760 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | smallcell lung cancer | view |
| DB00761 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00762 | gefitinib | Epidermal growth factor receptor | lung cancer | view |
| DB00763 | bevacizumab | Vascular endothelial growth factor | non small cell lung cancer | view |
| DB00764 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00765 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |